Krensky A M, Clayberger C
Department of Pediatrics, Stanford University, CA 94305.
Pediatr Nephrol. 1994 Dec;8(6):772-9. doi: 10.1007/BF00869120.
Immunological tolerance is the ultimate goal of transplantation immunobiology. Current therapies involve nonspecific immunosuppression with concomitant risks for infection, malignancy, and drug-specific side effects. By inducing specific immune unresponsiveness to the graft it should be possible to maintain transplants without the need for chronic drug administration and without the risk of nonspecific immunosuppression. This review highlights recent progress in the understanding of immunological tolerance, with special attention to the long-term prospects for successful induction of tolerance in renal transplant patients.
免疫耐受是移植免疫生物学的最终目标。目前的治疗方法包括非特异性免疫抑制,同时存在感染、恶性肿瘤和药物特异性副作用的风险。通过诱导对移植物的特异性免疫无反应,应该有可能在无需长期给药且不存在非特异性免疫抑制风险的情况下维持移植。本综述重点介绍了在免疫耐受理解方面的最新进展,特别关注肾移植患者成功诱导耐受的长期前景。